Zdrowie i gospodarka · 03/08/2023
FDA Announces Draft Guidance for Industry on Fixed-Combinations and Single-Entity Antiretrovirals for HIV-1 Treatment and Prevention
The FDA is releasing a draft guidance for industry on single-entity antiretroviral and fixed-combination drug products for HIV-1 treatment and prevention, intended for procurement under PEPFAR, replacing a 2006 guidance.